Detalhe da pesquisa
1.
Tocilizumab Treatment in COVID-19 Patients: Comparing Cutaneous Disease and Adverse Drug Effects.
J Drugs Dermatol
; 22(12): e42-e43, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051828
2.
Nirmatrelvir-ritonivir, COVID-19, and possible adverse cutaneous reactions.
Dermatol Online J
; 29(1)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040906
3.
Remdesivir Use in COVID-19 Patients: Cutaneous Adverse Effect or Disease Manifestation?
J Drugs Dermatol
; 20(5): 575, 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33938699
4.
Coronavirus Vaccination Adverse Reactions and the Role of the Dermatologist.
J Drugs Dermatol
; 20(3): 351-352, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683080
5.
Parental leave in medical school: supporting students as parents.
J Osteopath Med
; 122(5): 229-233, 2022 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179008
6.
Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic.
J Pharm Pract
; 35(1): 120-125, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32734810